Informations générales (source: ClinicalTrials.gov)
Study of the Role of Acid Sensing Ion Channels (ASICs) in Human Inflammatory Pain
Observational
Centre Hospitalier Universitaire de Nice (Voir sur ClinicalTrials)
novembre 2012
décembre 2018
29 juin 2024
In recent years, ion channels have emerged as new therapeutic targets for pain. Among
these channels, ASICs (Acid Sensing Ion Channels) are of particular interest because they
are directly activated by extracellular acidity, which is a major cause of pain. Indeed,
many painful conditions such as ischemia, inflammation, tumor development or tissue
incision are accompanied by tissue acidification. ASIC are excitatory ion channels that
are expressed in neurons, including nociceptive sensory neurons. In humans, the use of
amiloride, a nonspecific inhibitor of ASICs, has demonstrated their role in the
perception of pain induced by subcutaneous injections of acidic solutions. ASICs thus
appear as new candidates capable of mediating pain in humans. A growing number of data
suggests that, in addition to protons, ASICs may also be activated by one or more
endogenous compounds produced during inflammation. The purpose of this research project
is to identify these compounds by testing the effects of human inflammatory exudates on
ASICs activity. The discovery of such compounds would definitely validate ASICs as novel
therapeutic targets for pain treatment in humans
Etablissements
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
Service de Rhumatologie - 06000 - Nice - France | Véronique BREUIL, Pr | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- septic arthritis
- gonarthrosis in push-inflammatory
- microcrystalline arthropathies
- chronic inflammatory rheumatism
- septic arthritis
- gonarthrosis in push-inflammatory
- microcrystalline arthropathies
- chronic inflammatory rheumatism
- refusal to participate in the protocol